Dear All, I wrote in a 26 Oct 2021 newsletter about an RFP focused on Antimicrobial Stewardship (AMS) activities to address health inequities arising from socioeconomic disparities. The core concept is that AMR disproportionally impacts underserved patient communities world-wide. Racial minorities, ethnic minorities, and elderly patients in both developed and developing economies are all at risk. Building on

Dear All, Our colleagues at ICARS have just announced a fascinating grant opportunity focused on environmental AMR. They don’t want surveillance — they want research on to how to intervene! Excerpting from their website: ICARS seeks “projects to mitigate the evolution and transmission of resistance in the natural or built environment”. Proposals are expected to

Dear All, Another AMR-focused BAA (Broad Agency Announcement) is out, now from NIAID! Entitled “2024 NIAID Omnibus Broad Agency Announcement: Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases,” you can find the solicitation here. The BAA calls for proposals in 3 research areas: Research Area 001: Vaccine Candidates: The goal here is technology platforms

Dear All, Two funding opportunities to call to your attention! First, ENABLE-2 has just launched an Open Call for antibacterial programs throughout Europe. The ENABLE-2 platform supports the development of direct-acting systemic antibacterial compounds (potentiator molecules are also in scope, e.g. β-lactamase inhibitors) by providing experimental support and expert advice. The goal of ENABLE-2 is